Glover Steve C 13D and 13G filings for ZyVersa Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-05-12 2:58 pm Sale |
2023-04-28 | 13D | ZyVersa Therapeutics, Inc. ZVSA |
Glover Steve C | 4,058 6.760% |
-231 (-5.39%) |
Filing |
| 2022-12-22 5:30 pm Purchase |
2022-12-12 | 13D | ZyVersa Therapeutics, Inc. ZVSA |
Glover Steve C | 4,289 15.100% |
4,289 (New Position) |
Filing |